Using an integrated analysis of genomic and transcriptomic profiles from esophageal squamous cell carcinoma patients, we had identified and a valuable immunohistochemistry panel comprising ANO1 and MMP3. Patients could be stratified into three subgroups with different risks based on the positive marker status of two genes. The gene discussed is ANO1; the disease is esophageal squamous cell carcinoma.